Clinical Trial Update: The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing safety and efficacy of naltrexone and scopolamine in treatment of major depression has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Naltrexone (Naltrexone)
• SCOPOLAMINE (SCOPOLAMINE)

Snippet

Sponsor: The Taub Group | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2019-05-20